María Natalia Gandur Quiroga: Case Discussion – Treatment Options for Metastatic pRCC
María Natalia Gandur Quiroga, Coordinator in charge of the Urological Clinical Service of the Angel H.Roffo Institute, shared on X:
“Case presentation.
Case 3: Sylvie, 55 years old
Diagnosed with metastatic pRCC.
ECOG PS: 2 (asthenia), KPS: 70%. Treatment poll results:
– Pembrolizumab + Lenvatinib leads with 34%.
– Followed by Ipilimumab + Nivolumab and Nivolumab + Cabozantinib (both at 19%).
Multidisciplinary input is key!”
More posts featuring María Natalia Gandur Quiroga.
María Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Ángel H. Roffo Oncology Institute in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies.
Her research focuses on clinical trials with aims to improve the treatment of patients with urologic tumors. She is an active member of the European Association for Cancer Research, Argentinian Medical Association and American Society of Clinical Oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023